Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.79 USD 8.45% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Arcus Biosciences Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Arcus Biosciences Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(53)
(59)
(63)
(51)
(50)
(54)
(69)
(80)
(85)
(95)
(112)
(88)
(123)
(168)
(199)
(278)
53
57
67
80
(267)
(279)
(287)
(294)
(307)
(231)
(249)
(270)
Depreciation & Amortization
3
3
3
4
4
4
4
4
4
3
3
3
3
3
3
3
4
5
5
6
6
7
7
7
8
9
9
10
Stock-Based Compensation
0
1
2
3
4
5
6
8
9
11
13
16
22
31
40
49
55
59
61
62
65
67
70
72
73
74
76
77
Other Non-Cash Items
1
2
1
1
2
2
4
6
8
9
12
16
23
33
44
54
63
72
76
77
76
70
67
65
64
83
83
83
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
(3)
0
0
0
5
0
0
0
Change in Working Capital
25
26
26
26
1
2
6
(1)
0
(6)
4
220
208
207
178
(23)
(376)
330
325
283
623
(112)
(92)
(66)
(71)
(71)
(90)
19
Cash from Operating Activities
(25)
N/A
(29)
-14%
(33)
-14%
(20)
+38%
(43)
-111%
(47)
-8%
(56)
-19%
(71)
-28%
(74)
-3%
(88)
-20%
(92)
-5%
152
N/A
111
-27%
76
-31%
26
-66%
(244)
N/A
(256)
-5%
464
N/A
473
+2%
446
-6%
438
-2%
(314)
N/A
(306)
+3%
(288)
+6%
(306)
-6%
(210)
+31%
(247)
-18%
(158)
+36%
Investing Cash Flow
Capital Expenditures
(6)
(5)
(4)
(4)
(4)
(3)
(3)
(2)
(2)
(2)
(1)
(2)
(3)
(7)
(12)
(19)
(26)
(25)
(21)
(14)
(6)
(6)
(10)
(18)
(24)
(25)
(20)
(11)
Other Items
(44)
(45)
(59)
(154)
(110)
(79)
(37)
76
61
87
(28)
(445)
(431)
(405)
(309)
(4)
22
(310)
(532)
(427)
(407)
(10)
235
231
218
(79)
(47)
(96)
Cash from Investing Activities
(49)
N/A
(49)
N/A
(62)
-26%
(158)
-155%
(113)
+28%
(83)
+27%
(40)
+52%
74
N/A
59
-20%
85
+44%
(29)
N/A
(446)
-1 449%
(434)
+3%
(412)
+5%
(322)
+22%
(23)
+93%
(4)
+83%
(335)
-8 485%
(553)
-65%
(441)
+20%
(413)
+6%
(16)
+96%
225
N/A
213
-6%
194
-9%
(104)
N/A
(67)
+36%
(107)
-60%
Financing Cash Flow
Net Issuance of Common Stock
108
237
236
235
129
(0)
1
1
1
2
330
438
439
660
334
227
232
20
22
23
23
14
33
36
33
261
241
237
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47
Other
(0)
(1)
(1)
(1)
(0)
0
0
0
0
0
0
0
0
0
0
0
5
10
10
10
10
5
5
5
0
0
(1)
(2)
Cash from Financing Activities
107
N/A
237
+120%
235
-1%
235
0%
129
-45%
(0)
N/A
1
N/A
1
N/A
1
-21%
2
+55%
330
+19 312%
438
+33%
439
+0%
660
+50%
334
-49%
227
-32%
237
+4%
30
-87%
32
+7%
33
+4%
33
-1%
19
-42%
38
+97%
41
+9%
33
-20%
261
+691%
240
-8%
282
+18%
Change in Cash
Net Change in Cash
33
N/A
159
+379%
140
-12%
56
-60%
(27)
N/A
(130)
-374%
(94)
+27%
4
N/A
(13)
N/A
(1)
+90%
209
N/A
143
-32%
116
-19%
325
+181%
38
-88%
(40)
N/A
(23)
+43%
159
N/A
(48)
N/A
38
N/A
58
+52%
(311)
N/A
(43)
+86%
(34)
+21%
(79)
-134%
(53)
+33%
(74)
-40%
17
N/A
Free Cash Flow
Free Cash Flow
(31)
N/A
(33)
-8%
(36)
-9%
(24)
+33%
(47)
-93%
(50)
-7%
(58)
-16%
(73)
-26%
(75)
-3%
(90)
-19%
(93)
-4%
150
N/A
108
-28%
70
-36%
14
-80%
(263)
N/A
(282)
-7%
439
N/A
452
+3%
432
-5%
432
+0%
(320)
N/A
(315)
+1%
(306)
+3%
(330)
-8%
(235)
+29%
(267)
-14%
(169)
+37%

See Also

Discover More